Topic is: Transfer of a developed Covid vaccine from a European based pharmaceutical manufacturer to a European based contract Manufacturing Organisation (CMO).

Initiate: Identify a high-end overview of the requirements, gaps and risks involved in the TT from the European based pharmaceutical manufacturer to a European based CMO

Sending and receiving site information required

What are the Validation Master Plan (VMP) main areas of focus such as facilities, personnel & cleaning etc

Outline the potential gaps and risks with the TT in the VMP areas mentioned above